Compare Ionis Pharmaceuticals Inc. Common Stock (IONS) vs VF Corp (VFC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ionis Pharmaceuticals Inc. Common Stock vs VF Corp — how do they compare? Ionis Pharmaceuticals Inc. Common Stock trades at $43.32 (market cap $7.10B), while VF Corp trades at $16.6 (market cap $6.48B). The key difference: Ionis Pharmaceuticals Inc. Common Stock and VF Corp are close in size by market cap, and VF Corp pays a 2.18% dividend while Ionis Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ionis Pharmaceuticals Inc. Common Stock for 0 Days and VF Corp for 64 Days on average.
| IONS | VFC | |
|---|---|---|
Market Cap | $7.10B | $6.48B |
Volume | 2,027,457 | 18,946,837 |
Sector | Health | Consumer Cyclical |
52-Week High | $86.50 | $21.55 |
52-Week Low | $42.38 | $12.62 |
Typical Hold Time | 0 Days | 64 Days |
Enterprise Value | $6.66B | $10.76B |
Dividend Yield | — | 2.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
VFC trades at $16.07, up 1.77% today, with bullish technical signals from moving averages and ADX indicators. The company reported mixed quarterly results with a Q4 2025 earnings beat but subsequent misses, while revenue declined from $11.8B in 2022 to $9.5B in 2025. Analyst consensus shows a Hold rating with a $18.18 price target, representing 13% upside potential from current levels.
VFC's turnaround faces execution risks from Vans brand weakness despite strength in Outdoor segments. The stock trades at discounted valuations with P/S of 0.69, but negative net income and declining revenue trends require careful monitoring. Dividend sustainability remains a concern following the recent 82% cut, though institutional buying and technical momentum provide near-term support.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ionis Pharmaceuticals Inc. Common Stock
Ionis Pharmaceuticals Inc. is a biopharmaceutical company that develops RNA-targeted medicines using its antisense technology, with marketed treatments in neurology and cardiometabolic disease.
Read more on IONS →About VF Corp
VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.
Read more on VFC →
